Your browser doesn't support javascript.
loading
Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders.
Sabbadin, Chiara; Beggiao, Francesca; Keiko Vedolin, Carlotta; Orlando, Gloria; Ragazzi, Eugenio; Ceccato, Filippo; Barbot, Mattia; Bordin, Luciana; Donà, Gabriella; Andrisani, Alessandra; Belloni Fortina, Anna; Scaroni, Carla; Armanini, Decio.
Afiliación
  • Sabbadin C; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Beggiao F; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Keiko Vedolin C; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Orlando G; Department of Medicine, Pediatric Dermatology Unit, University of Padova, Padova, Italy.
  • Ragazzi E; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
  • Ceccato F; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Barbot M; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Bordin L; Department of Molecular Medicine-Biological Chemistry, University of Padova, Padova, Italy.
  • Donà G; Department of Molecular Medicine-Biological Chemistry, University of Padova, Padova, Italy.
  • Andrisani A; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Belloni Fortina A; Department of Medicine, Pediatric Dermatology Unit, University of Padova, Padova, Italy.
  • Scaroni C; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
  • Armanini D; Department of Medicine, Endocrinology Unit, University of Padova, Padova, Italy.
Article en En | MEDLINE | ID: mdl-35532249

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Espironolactona Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Emiratos Árabes Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Espironolactona Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Emiratos Árabes Unidos